Share

March 22, 2022; 98 (12) Editorial

Costs for Children With Drug-Resistant Epilepsy

Is Care Value Based?

Anup D. Patel, Christopher W. Beatty
First published February 15, 2022, DOI: https://doi.org/10.1212/WNL.0000000000200104
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
47

Share

Article Information

vol. 98 no. 12 475-476
DOI: 
https://doi.org/10.1212/WNL.0000000000200104
PubMed: 
35169005
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published February 15, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Anup D. Patel, MD and
    2. Christopher W. Beatty, MD
  1. Anup D. Patel, MD and
    2. Scientific Advisory Boards:

    1. <br>Neurelis<br>

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. <br>Greenwich Biosciences<br>

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. <br>Webinar Development for Medscape<br>

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. <br>Stoke<br>Encoded<br>

    Research Support, Government Entities:

    1. <br>R01NR017794-01A, NIH/NINR Site PI: 08/01/2018 – 06/30/2023<br>HRSA-16-055 QI consultant: 01/01/2017 – 12/31/2021<br>R21NR017633-01, NIH/NINR Site SI: 09/01/2018 – 08/01/2020<br>

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. <br>Pediatric Epilepsy Research Foundation (PERF)<br> Signature: /Anup D. Patel/ Date: 12/22/2021<br><br>

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Christopher W. Beatty, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Neurology (A.D.P., C.W.B.) and Center for Clinical Excellence (A.D.P.), Nationwide Children's Hospital; and Department of Pediatrics (A.D.P., C.W.B.), The Ohio State University College of Medicine, Columbus.
  1. Correspondence
    Dr. Patel anup.patel{at}nationwidechildrens.org
View Full Text

Article usage

Article usage: February 2022 to May 2022

AbstractFullPdfSource
Feb 20220017Highwire
Mar 20224363723Highwire
Apr 2022217145Highwire
May 202218422Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me